GGrantIndex
Sort

130,381 grants matching hiv

TULANE/LSU PEDIATRIC AIDS CLINICAL TRIALS UNIT

$869,072
Tulane University Of Louisiana · U01 · FY2000 · AI

Virologic Correlates of Heterosexual Transmission

$868,993
Emory University · R01 · FY2005 · AI

Recipient Epidemiology and Donor Evaluation Study III (REDS-III) DCC

$868,903
Research Triangle Institute · N01 · FY2012 · HL

Prospective Evaluation of Antiviral Therapy and Cardiac Health

$868,866
Judith S. Currier · University Of California Los Angeles · R01 · FY2008 · HL

ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY

$868,634
University Of Louisiana At Lafayette · U42 · FY2003 · RR

Transcriptome resources for comparative primate models of lentivirus infection

$868,612
Guido Silvestri · Emory University · R24 · FY2013 · OD

Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules

$868,549
John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta

$868,544
David J Volsky · Icahn School Of Medicine At Mount Sinai · R56 · FY2020 · NS

Enhanced latency reversal and reservoir clearance in macaques

$868,475
Ann M Chahroudi · Emory University · R37 · FY2023 · AI

Effectiveness of comprehensive ETE interventions in the dental settingÂ

$868,338
Michael T Yin · Columbia University Health Sciences · UH3 · FY2023 · DE

ADULT AIDS CLINICAL TRIALS UNIT

$868,304
University Of Pittsburgh At Pittsburgh · U01 · FY2000 · AI

U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT

$868,300
University Of Texas Sw Med Ctr/Dallas · U01 · FY2000 · AI

PROVISION OF FULL ACCESS HOME BASED CONFIDENTIAL HIV COUNSELING AND TESTING

$868,231
Elly Muganzi · Integrated Community Based Initiatives · U2G · FY2009 · PS

Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine

$868,211
Raphael Dolin · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI

Mechanisms Blocking HIV-1 Superinfection

$868,150
J. David Gladstone Institutes · R01 · FY2005 · AI

Activated Sugars, Oligosaccharides and Glycans for Antiviral Research

$868,039
Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2022 · GM

Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention

$867,958
Marc Michael Baum · Oak Crest Institute Of Science · R01 · FY2015 · AI

Examining Modifiable Psychosocial Predictors of HIV Seroconversion in a Large Nationwide Cohort of High Risk Men

$867,838
H. Jonathon Rendina · Whitman-Walker Institute, Inc. · UH3 · FY2021 · AI

Stanford AIDS Clinical Trials Unit

$867,835
Andrew Zolopa · Stanford University · U01 · FY2007 · AI

UNIVERSITY OF P.R PEDIATRIC AIDS CLINICAL TRIALS UNIT

$867,789
University Of Puerto Rico Med Sciences · U01 · FY2004 · AI

Pathogenomics of Chlamydial Infection

$867,771
Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Chlamydial Immunity and Vaccine Development

$867,771
Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

The Functional Significance of CTL Escape

$867,756
David I Watkins · University Of Wisconsin-Madison · R01 · FY2006 · AI

NINDS Quantitative MRI Core Facility

$867,749
Govind Nair · National Institute Of Neurological Disorders And Stroke · ZIC · FY2024 · NS

Effects of HIV and ART on myelination in the adolescent

$867,647
Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2021 · MH